BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

462 related articles for article (PubMed ID: 34071314)

  • 1. Sialic Acid-Siglec Axis in Human Immune Regulation, Involvement in Autoimmunity and Cancer and Potential Therapeutic Treatments.
    Gianchecchi E; Arena A; Fierabracci A
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34071314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Siglec and anti-Siglec therapies.
    Murugesan G; Weigle B; Crocker PR
    Curr Opin Chem Biol; 2021 Jun; 62():34-42. PubMed ID: 33607404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tools to study and target the Siglec-sialic acid axis in cancer.
    Läubli H; Kawanishi K; George Vazhappilly C; Matar R; Merheb M; Sarwar Siddiqui S
    FEBS J; 2021 Nov; 288(21):6206-6225. PubMed ID: 33251699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting the Siglec-Sialic Acid Immune Axis in Cancer: Current and Future Approaches.
    Läubli H; Nalle SC; Maslyar D
    Cancer Immunol Res; 2022 Dec; 10(12):1423-1432. PubMed ID: 36264237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Roles of the Siglec family in bone and bone homeostasis.
    Ye Z; Wang Y; Xiang B; Wang H; Tao H; Zhang C; Zhang S; Sun D; Luo F; Song L
    Biomed Pharmacother; 2023 Sep; 165():115064. PubMed ID: 37413904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Siglec Signaling in the Tumor Microenvironment.
    van Houtum EJH; Büll C; Cornelissen LAM; Adema GJ
    Front Immunol; 2021; 12():790317. PubMed ID: 34966391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of Immune Tolerance via Siglec-Sialic Acid Interactions.
    Lübbers J; Rodríguez E; van Kooyk Y
    Front Immunol; 2018; 9():2807. PubMed ID: 30581432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-canonical roles of Siglecs: Beyond sialic acid-binding and immune cell modulation.
    Siddiqui SS
    Mol Aspects Med; 2023 Apr; 90():101145. PubMed ID: 36153172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The ligand interactions of B cell Siglecs are involved in the prevention of autoimmunity to sialylated self-antigens and in the quality control of signaling-competent B cells.
    Tsubata T
    Int Immunol; 2023 Oct; 35(10):461-473. PubMed ID: 37504378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery, classification, evolution and diversity of Siglecs.
    Angata T; Varki A
    Mol Aspects Med; 2023 Apr; 90():101117. PubMed ID: 35989204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting sialic acid-Siglec interactions to reverse immune suppression in cancer.
    Adams OJ; Stanczak MA; von Gunten S; Läubli H
    Glycobiology; 2018 Sep; 28(9):640-647. PubMed ID: 29309569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sugar Free: Novel Immunotherapeutic Approaches Targeting Siglecs and Sialic Acids to Enhance Natural Killer Cell Cytotoxicity Against Cancer.
    Daly J; Carlsten M; O'Dwyer M
    Front Immunol; 2019; 10():1047. PubMed ID: 31143186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Possible Influences of Endogenous and Exogenous Ligands on the Evolution of Human Siglecs.
    Angata T
    Front Immunol; 2018; 9():2885. PubMed ID: 30564250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Siglecs on autoimmune diseases.
    Brzezicka KA; Paulson JC
    Mol Aspects Med; 2023 Apr; 90():101140. PubMed ID: 36055802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are humans prone to autoimmunity? Implications from evolutionary changes in hominin sialic acid biology.
    Varki A
    J Autoimmun; 2017 Sep; 83():134-142. PubMed ID: 28755952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensing the neuronal glycocalyx by glial sialic acid binding immunoglobulin-like lectins.
    Linnartz-Gerlach B; Mathews M; Neumann H
    Neuroscience; 2014 Sep; 275():113-24. PubMed ID: 24924144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leishmania donovani Utilize Sialic Acids for Binding and Phagocytosis in the Macrophages through Selective Utilization of Siglecs and Impair the Innate Immune Arm.
    Roy S; Mandal C
    PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004904. PubMed ID: 27494323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current Status on Therapeutic Molecules Targeting Siglec Receptors.
    Lenza MP; Atxabal U; Oyenarte I; Jiménez-Barbero J; Ereño-Orbea J
    Cells; 2020 Dec; 9(12):. PubMed ID: 33333862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sialylation pattern in lung epithelial cell line and Siglecs expression in monocytic THP-1 cells as cellular indicators of cigarette smoke - induced pathology in vitro.
    Wielgat P; Trofimiuk E; Czarnomysy R; Holownia A; Braszko JJ
    Exp Lung Res; 2018 Apr; 44(3):167-177. PubMed ID: 29781747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B Cell Siglecs-News on Signaling and Its Interplay With Ligand Binding.
    Meyer SJ; Linder AT; Brandl C; Nitschke L
    Front Immunol; 2018; 9():2820. PubMed ID: 30559744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.